BioIVT

About:

BioIVT is a worldwide provider of biological and in vitro products to pharmaceutical and biotechnology organizations

Top Investors: NXT Capital, Thompson Street Capital Partners, NorthStar Capital, Lineage Capital

Description:

Headquartered in Westbury, NY, BioIVT is the leading provider of biological and in vitro products to the biopharmaceutical, diagnostic, and biotechnology organizations. BioIVT’s products are used in drug discovery, biomarker, toxicology, bioanalytical, and ADME research. The company’s products and value added services enable its clients to significantly reduce the time and expense of bringing new drugs and diagnostics to market.

Total Funding Amount:

$45M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Westbury, New York, United States

Founded Date:

1981-01-01

Founders:

Jeffrey Gatz

Number of Employees:

251-500

Last Funding Date:

2013-07-16

IPO Status:

Private

Industries: